MedPath

Remote Ischemic Preconditioning During Cardiopulmonary Bypass

Not Applicable
Withdrawn
Conditions
Lactic Acidosis
Interventions
Device: Non inflated cuff
Device: Inflated cuff
Registration Number
NCT03723993
Lead Sponsor
Fayoum University
Brief Summary

The objective of study is to detect effect of remote ischemic preconditioning on serum lactate levels during and after cardiac surgery with cardiopulmonary bypass in addition to its effect on cardiac and renal clinical outcomes.

Detailed Description

Remote ischemic preconditioning (RIPC) is a phenomenon where transient non-injurious ischemia/ reperfusion episodes applied to an organ away from the heart can protect the myocardium from ischemia/reperfusion injury. RIPC has been found to be an attractive strategy to reduce myocardial injury and improve outcome in patients undergoing cardiac surgery. The exact mechanisms of this protection are not yet known, although stimulation of prosurvival intracellular kinase responses and inhibition of inflammatory pathways each play a role.

RIPC can be performed by noninvasive inflation and deflation of a standard blood pressure cuff or pneumatic tourniquet on the upper or lower limbs to induce brief ischemia and reperfusion, which is the mechanism by which injury in patients undergoing open cardiac surgery occurs.

ANESTHETIC TECHNIQUE All patients will be preoperatively examined and investigated by complete blood count, coagulation profile, renal and kidney functions and electrolytes. Electrocardiography, chest x ray and echocardiography will be routinely done. Coronary angiography and carotid arterial duplex will be requested in patients prepared for coronary artery bypass graft (CABG).

Patient will be premedicated by intramuscular injection of 10mg morphine in the morning of the operation. Before induction of anesthesia, a five-lead electrocardiography system will be applied to monitor heart rate, rhythm, and ST segments (leads II and V5). A pulse oximeter probe will be attached, and a peripheral venous cannula will be placed. For measurement of arterial pressure and blood sampling, a 20 G cannula will be inserted into either right or left radial artery under local anesthesia. General anesthesia will be induced by fentanyl (3-5 μg/kg), propofol titrated according to response, followed by atracurium (0.5 mg/kg).

Trachea will be intubated, patients will be mechanically ventilated with oxygen in air so as to achieve normocarbia. This will be confirmed by radial arterial blood gas analysis. An esophageal temperature probe and a Foley catheter will also be placed.

For drug infusion, a triple-lumen central venous catheter will be inserted via the right internal jugular vein.

Anesthesia will be maintained by inhaled isoflurane, with additional fentanyl injected prior to skin incision as well as sternotomy and atracurium infusion for continued muscle relaxation.

During extracorporeal circulation, patients will receive propofol infusion in addition to atracurium infusion.

Before initiation of cardiopulmonary bypass (CPB), the patients will receive intravenously tranexamic acid (2 g) and heparin (300-500 units/kg body weight) to achieve an activated clotting time \> 400 s. CPB was instituted via an ascending aortic cannula and a two-stage right atrial cannula. Before, during, and after CPB (pump blood flow: 2.4 l/min/m2), mean arterial pressure was adjusted to exceed 60 mmHg. Cardiac arrest will be induced with cold antegrade crystalloid cardioplegia (St Thomas solution) or warm intermittent antegrade blood cardioplegia. Lactate-enriched Ringer's solution will be added to the CPB circuit to maintain reservoir volume when needed, and packed red blood cells will be added when hemoglobin concentration decrease to less than 7 g/dl.

After rewarming the patient to 37°C and separation from CPB, reversal of heparin by protamine sulfate, and sternal closure, the patients will be transferred to the intensive care unit.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Patients 18 years of age or older
  • Elective cardiovascular surgery requiring cardiopulmonary bypass either for CABG or valve replacement.
Exclusion Criteria
  • Patients with emergency surgeries.
  • Off pump heart surgery.
  • Hepatic affection (INR>2).
  • Renal affection (creatinine >1.6 mg/dl for men and >1.4 mg/dl for women).
  • Peripheral vascular disease affecting upper limbs.
  • Patients taking the antidiabetic sulphonylurea glyburide ( glibenclamide) or receiving nicorandil drug therapy will be excluded because these agents have been shown to abolish preconditioning.
  • Patients being considered for radial artery conduit harvesting.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control groupNon inflated cuffcontrol group will have non inflated cuff around the arm.
RIPC groupInflated cuffInflated cuff will be done systematically and regularly
Primary Outcome Measures
NameTimeMethod
Serum lactate level1 minute at the end of operation

mmol/l from arterial blood gas sample

Secondary Outcome Measures
NameTimeMethod
Serum creatinine level72 hours postoperatively

mmol/L

Acute kidney injury (AKI) score72 hours postoperatively

Grade 1: serum creatinine rise of 150%-200% of baseline and/or urine output \<0.5 mL/kg/h for \>6 contiguous hours.

Grade 2: serum creatinine rise of 200%-300% of baseline and/or urine output \<0.5 mL/kg/h for \>12 contiguous hours.

Grade 3: serum creatinine rise of \>300% of baseline and/or urine output \<0.3 mL/kg/h for \>24 h or anuria for 12 h.

Serum sodium level5 minutes before beginning of operation

milliequivalent/L

Serum lactate level72 hours postoperatively.

mmol/l from arterial blood gas sample

Heart rateEvery 30 minutes for 6 hours during surgery except at cardiopulmonary bypass as there is cardioplegia

beat per minute from electrocardiogram

Left ventricular ejection fraction (LVEF)48 hours after the operation

measured in percentage derived from echocardiography

Central venous pressure1 minute after the end of operation

from central venous catheter measured in cm H2O

Arterial oxygen pressureEvery 6 hours for 24 hours in the ICU

From arterial blood gas sampling

Arterial carbon dioxide pressureEvery 6 hours for 24 hours in the ICU

From arterial blood gas sampling

Power of hydrogen (pH)Every 6 hours for 24 hours in the ICU

From arterial blood gas sampling

Standard bicarbonate levelEvery 6 hours for 24 hours in the ICU

From arterial blood gas sampling

Diastolic blood pressureEvery 30 minutes for 6 hours during surgery except at cardiopulmonary bypass as there is cardioplegia and no pulsatile blood pressure

Measured by mmHg from invasive arterial blood pressure

Left ventricular fractional shortening (LVFS)72 hours after the operation

measured in percentage derived from echocardiography

Serum potassium level5 minutes after ICU admission

milliequivalent/L

Systolic blood pressureEvery 30 minutes for 6 hours during surgery except at cardiopulmonary bypass as there is cardioplegia and no pulsatile blood pressure

Measured by mmHg from invasive arterial blood pressure

Serum urea level5 minutes after ICU admission

mmol/L

Trial Locations

Locations (1)

Mohamed Hamed

🇪🇬

Fayoum, Egypt

© Copyright 2025. All Rights Reserved by MedPath